DK2988733T3 - Farmaceutisk sammensætning indeholdende krystallin macitentan - Google Patents

Farmaceutisk sammensætning indeholdende krystallin macitentan Download PDF

Info

Publication number
DK2988733T3
DK2988733T3 DK14721256.7T DK14721256T DK2988733T3 DK 2988733 T3 DK2988733 T3 DK 2988733T3 DK 14721256 T DK14721256 T DK 14721256T DK 2988733 T3 DK2988733 T3 DK 2988733T3
Authority
DK
Denmark
Prior art keywords
macitentan
crystaline
pharmaceutical composition
composition containing
pharmaceutical
Prior art date
Application number
DK14721256.7T
Other languages
English (en)
Inventor
Ludwig Englmeier
Marijan Stefinovic
Johannes Raneburger
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48143162&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2988733(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sandoz Ag filed Critical Sandoz Ag
Application granted granted Critical
Publication of DK2988733T3 publication Critical patent/DK2988733T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/03Containers specially adapted for medical or pharmaceutical purposes for pills or tablets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65DCONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D65/00Wrappers or flexible covers; Packaging materials of special type or form
    • B65D65/38Packaging materials of special type or form
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65DCONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D2565/00Wrappers or flexible covers; Packaging materials of special type or form
    • B65D2565/38Packaging materials of special type or form
    • B65D2565/381Details of packaging materials of special type or form
    • B65D2565/388Materials used for their gas-permeability

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Mechanical Engineering (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK14721256.7T 2013-04-22 2014-04-17 Farmaceutisk sammensætning indeholdende krystallin macitentan DK2988733T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13164724 2013-04-22
PCT/EP2014/057883 WO2014173805A1 (en) 2013-04-22 2014-04-17 Pharmaceutical composition containing crystalline macitentan

Publications (1)

Publication Number Publication Date
DK2988733T3 true DK2988733T3 (da) 2019-07-01

Family

ID=48143162

Family Applications (1)

Application Number Title Priority Date Filing Date
DK14721256.7T DK2988733T3 (da) 2013-04-22 2014-04-17 Farmaceutisk sammensætning indeholdende krystallin macitentan

Country Status (12)

Country Link
US (2) US9730932B2 (da)
EP (1) EP2988733B1 (da)
AU (2) AU2014257719B2 (da)
CA (1) CA2908410A1 (da)
DE (1) DE14721256T1 (da)
DK (1) DK2988733T3 (da)
ES (1) ES2729191T3 (da)
HU (1) HUE043804T2 (da)
PL (1) PL2988733T3 (da)
PT (1) PT2988733T (da)
TR (1) TR201906685T4 (da)
WO (1) WO2014173805A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE14721256T1 (de) 2013-04-22 2017-03-16 Sandoz Ag Pharmazeutische zusammensetzungen mit kristallinem macitentan
CN105461638A (zh) * 2015-12-10 2016-04-06 合肥久诺医药科技有限公司 一种马西替坦晶型及其制备方法
WO2018153925A1 (en) 2017-02-22 2018-08-30 Amneal Pharmaceuticals Company Gmbh Stable pharmaceutical compositions comprising macitentan
US20220249381A1 (en) 2019-07-05 2022-08-11 TECNIMEDE - Sociedade Técnico-medicinal, SA Compressed macitentan compositions, methods and uses thereof
WO2022045991A1 (en) * 2020-08-26 2022-03-03 Pharmacti̇ve İlaç Sanayi̇ Ve Ti̇caret A.Ş. Pharmaceutical compositions comprising macitentan and relevant excipients
WO2023038600A1 (en) * 2021-09-07 2023-03-16 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi A capsule formulation comprising macitentan
WO2023048684A2 (en) * 2021-09-22 2023-03-30 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi The tablet comprising macitentan
EP4154873A1 (en) * 2021-09-22 2023-03-29 Sanovel Ilac Sanayi Ve Ticaret A.S. The tablet comprising macitentan

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4721709A (en) * 1984-07-26 1988-01-26 Pyare Seth Novel pharmaceutical compositions containing hydrophobic practically water-insoluble drugs adsorbed on pharmaceutical excipients as carrier; process for their preparation and the use of said compositions
BRPI0116237B8 (pt) 2000-12-18 2021-05-25 Actelion Pharmaceuticals Ltd "composto de sulfamida, composição farmacêutica contendo o mesmo e seu uso como medicamento antagonista de receptor de endotelina".
RU2424805C2 (ru) * 2005-09-12 2011-07-27 Актелион Фармасьютиклз Лтд Стабильные фармацевтические композиции, включающие пиримидинсульфамид
AU2007280754B2 (en) * 2006-08-03 2013-02-28 Merck Patent Gmbh Packaging comprising pharmaceutical forms
DE14721256T1 (de) 2013-04-22 2017-03-16 Sandoz Ag Pharmazeutische zusammensetzungen mit kristallinem macitentan

Also Published As

Publication number Publication date
AU2016238890A1 (en) 2016-10-27
EP2988733A1 (en) 2016-03-02
AU2014257719B2 (en) 2016-07-07
PL2988733T3 (pl) 2019-09-30
PT2988733T (pt) 2019-06-04
WO2014173805A1 (en) 2014-10-30
ES2729191T3 (es) 2019-10-30
CA2908410A1 (en) 2014-10-30
US20180008603A1 (en) 2018-01-11
US20160074398A1 (en) 2016-03-17
HUE043804T2 (hu) 2019-09-30
AU2014257719A1 (en) 2015-09-17
US9730932B2 (en) 2017-08-15
EP2988733B1 (en) 2019-03-27
TR201906685T4 (tr) 2019-05-21
DE14721256T1 (de) 2017-03-16

Similar Documents

Publication Publication Date Title
DK3030262T3 (da) Kombineret farmaceutisk sammensætning
DK2970389T3 (da) Farmaceutiske forbindelser
DK2943549T3 (da) Synergistisk h2s-scavenger-sammensætning
DK3043778T3 (da) Farmaceutiske sammensætninger, der indeholder refametinib
BR112016010669A2 (pt) composição desinfetante
DK3027750T3 (da) Biokatalytisk sammensætning
HK1213182A1 (zh) 外用藥物組合物
DK2988733T3 (da) Farmaceutisk sammensætning indeholdende krystallin macitentan
DK2897594T3 (da) Farmaceutisk sammensætning
SG11201601477VA (en) Pharmaceutical composition
GB201320932D0 (en) Topical pharmaceutical composition
UA30071S (uk) Флакон для косметичних засобів
DK3003401T3 (da) Farmaceutisk præparat
HUP1300496A2 (hu) Stabil kombinációs gyógyszerkészítmény
HK1220143A1 (zh) 藥物組合物
DK3060213T3 (da) Farmaceutiske sammensætninger omfattende antibakterielle midler
DK3082855T3 (da) Sammensætning
TH1501001889A (th) องค์ประกอบเครื่องสำอาง
TH1501000622A (th) องค์ประกอบแชมพู
UA30187S (uk) Ампула
TH1401003526B (th) องค์ประกอบเครื่องสำอาง
UA26239S (uk) Пробка
UA28963S (uk) Пляшечка на ліки
TH1501000527B (th) จุกอุดรู
UA28964S (uk) Пляшечка на ліки